Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Antimicrobial Susceptibility Testing in Cystic Fibrosis: A Delphi approach to defining best practices

  • Read more about Antimicrobial Susceptibility Testing in Cystic Fibrosis: A Delphi approach to defining best practices

Minimal detectable change and minimal clinically important differences in modified shuttle walk test in children and adolescents with cystic fibrosis

  • Read more about Minimal detectable change and minimal clinically important differences in modified shuttle walk test in children and adolescents with cystic fibrosis

Insights into the variability of Nasal Potential Difference, a biomarker of CFTR activity

  • Read more about Insights into the variability of Nasal Potential Difference, a biomarker of CFTR activity

Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome

  • Read more about Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome

Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis

  • Read more about Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States

  • Read more about Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States

Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

  • Read more about Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

Measuring Knowledge of Disease  Management in Adolescents with Cystic Fibrosis: Initial Psychometric  Evaluation.

  • Read more about Measuring Knowledge of Disease  Management in Adolescents with Cystic Fibrosis: Initial Psychometric  Evaluation.

Cystic Fibrosis in Black African Children

  • Read more about Cystic Fibrosis in Black African Children

Decreased mRNA and protein stability of W1282X limits response to modulator therapy

  • Read more about Decreased mRNA and protein stability of W1282X limits response to modulator therapy
  • first
  • previous
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)